# Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)

> **NCT01231633** · NA · COMPLETED · sponsor: **Long Island Vitreoretinal Consultants** · enrollment: 27 (actual)

## Conditions studied

- Macular Edema
- Central Retinal Vein Occlusion

## Interventions

- **DRUG:** Ozurdex
- **DRUG:** Avastin

## Key facts

- **NCT ID:** NCT01231633
- **Lead sponsor:** Long Island Vitreoretinal Consultants
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01231633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01231633, "Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01231633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*